Johns Hopkins ABX Guide
Amantadine
INDICATIONS
FDA
FDA
- Influenza A (prophylaxis and treatment: no longer routinely recommended due to high incidence of resistant influenza strains, unless circulating strain known to be susceptible)
- Parkinson disease
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 9, 2022
Citation
Dzintars, Kathryn, and Paul G Auwaerter. "Amantadine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540013/all/Amantadine.
Dzintars K, Auwaerter PG. Amantadine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540013/all/Amantadine. Accessed July 28, 2025.
Dzintars, K., & Auwaerter, P. G. (2022). Amantadine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540013/all/Amantadine
Dzintars K, Auwaerter PG. Amantadine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2025 July 28]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540013/all/Amantadine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amantadine
ID - 540013
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Auwaerter,Paul,M.D.
Y1 - 2022/10/09/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540013/all/Amantadine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
